These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32429314)

  • 41. Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.
    Esposito M; Moores S; Naguleswaran A; Müller J; Hemphill A
    Int J Parasitol; 2007 Aug; 37(10):1143-52. PubMed ID: 17481636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.
    Lindsay DS; Butler JM; Rippey NS; Blagburn BL
    Am J Vet Res; 1996 Jan; 57(1):68-72. PubMed ID: 8720241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum.
    Müller J; Aguado A; Laleu B; Balmer V; Ritler D; Hemphill A
    Int J Parasitol; 2017 Oct; 47(12):801-809. PubMed ID: 28751177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of vaccination with Neospora caninum protein for prevention of fetal loss associated with experimentally induced neosporosis in sheep.
    Jenkins MC; Tuo W; Dubey JP
    Am J Vet Res; 2004 Oct; 65(10):1404-8. PubMed ID: 15524328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stage-specific expression of Nc SAG4 as a marker of chronic Neospora caninum infection in a mouse model.
    Aguado-Martínez A; Ortega-Mora LM; Alvarez-García G; Rodríguez-Marco S; Risco-Castillo V; Marugán-Hernández V; Fernández-García A
    Parasitology; 2009 Jun; 136(7):757-64. PubMed ID: 19402941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites.
    Zhang H; Compaore MK; Lee EG; Liao M; Zhang G; Sugimoto C; Fujisaki K; Nishikawa Y; Xuan X
    Mol Biochem Parasitol; 2007 Feb; 151(2):205-12. PubMed ID: 17156863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infection of primary canine duodenal epithelial cell cultures with Neospora caninum.
    Hemphill A; Vonlaufen N; Golaz JL; Burgener IA
    J Parasitol; 2009 Apr; 95(2):372-80. PubMed ID: 18821824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrauterine Neospora caninum inoculation of heifers and cows using contaminated semen with different numbers of tachyzoites.
    Serrano-Martínez E; Ferre I; Osoro K; Aduriz G; Mota RA; Martínez A; Del-Pozo I; Hidalgo CO; Ortega-Mora LM
    Theriogenology; 2007 Mar; 67(4):729-37. PubMed ID: 17126895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a murine monoclonal antibody generated against Neospora caninum tachyzoites by use of western blot analysis and immunoelectron microscopy.
    Cole RA; Lindsay DS; Dubey JP; Toivio-Kinnucan MA; Blagburn BL
    Am J Vet Res; 1994 Dec; 55(12):1717-22. PubMed ID: 7887516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii.
    Howe DK; Crawford AC; Lindsay D; Sibley LD
    Infect Immun; 1998 Nov; 66(11):5322-8. PubMed ID: 9784539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Canine Neutrophil Extracellular Traps Release Induced by the Apicomplexan Parasite
    Wei Z; Hermosilla C; Taubert A; He X; Wang X; Gong P; Li J; Yang Z; Zhang X
    Front Immunol; 2016; 7():436. PubMed ID: 27843440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In contrast to Toxoplasma gondii, Neospora caninum tachyzoites did not sustain multiplication in vitro at increased incubation temperatures.
    Rezende-Gondim MM; da Silva AV; Schares G; Gondim LF
    Vet Parasitol; 2017 Jan; 234():19-24. PubMed ID: 28115178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of cell surface- and dense granule-associated Neospora caninum proteins in tachyzoites and bradyzoites.
    Fuchs N; Sonda S; Gottstein B; Hemphill A
    J Parasitol; 1998 Aug; 84(4):753-8. PubMed ID: 9714206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigen, SAG1 and SRS2.
    Marsh AE; Howe DK; Wang G; Barr BC; Cannon N; Conrad PA
    Int J Parasitol; 1999 Oct; 29(10):1575-82. PubMed ID: 10608444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neospora caninum: identification of 19-, 38-, and 40-kDa surface antigens and a 33-kDa dense granule antigen using monoclonal antibodies.
    Schares G; Dubremetz JF; Dubey JP; Bärwald A; Loyens A; Conraths FJ
    Exp Parasitol; 1999 Jun; 92(2):109-19. PubMed ID: 10366536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tunicamycins, a class of nucleoside antibiotics similar to corynetoxins of the Rathayibacter toxicus, increase susceptibility of mice to Neospora caninum.
    Cao L; Zhang X; Tuo W
    Vet Parasitol; 2011 Apr; 177(1-2):13-9. PubMed ID: 21168974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.